Matrix is an early-stage venture capital firm, investing from idea through Series A. As a close-knit team of former founders and company builders, we've partnered with companies from Apple and FedEx to Oculus and Canva.
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 55
Date | Name | Website | Total Raised | Location |
- | LogRocket | logrocket.com | $55M | United Sta... |
- | Optical In... | acacia-inc.com | $20M | United Sta... |
- | Trisk Bio | triskbio.com | - | United Kin... |
- | Namely | namely.com | $217.05M | United Sta... |
- | Earnin | earnin.com | $125M | United Sta... |
- | Emerge Too... | emergetools.com | $1.7M | United Sta... |
- | Nubis Comm... | nubis-inc.com | - | United Sta... |
- | nference | nference.ai | $71M | United Sta... |
- | Apartment ... | apartmentlist.com | $101M | - |
- | Bonsai | hellobonsai.com | $120K | United Sta... |
Show more
Mentions in press and media 4
Date | Title | Description |
20.09.2024 | Mevo's $19M Funding: A Digital Prescription Revolution in Brazil | In a world where convenience reigns supreme, Mevo is poised to change the prescription landscape in Brazil. The São Paulo-based startup recently secured $19 million in Series B funding, a move that could redefine how millions access medicat... |
18.09.2024 | Mevo Raises $19M to Revolutionize Digital Prescriptions in Brazil | What You Should Know: – Mevo, a digital prescription platform in Brazil, announced today that it has raised $19M in Series B funding. – The investment round was led by Matrix, with participation from Jefferson River Capital (former Blacksto... |
11.10.2023 | YC’s Health & Bio Summit is coming to SF in December — apply now to attend | The last two batches at YC were some of the absolute strongest we've ever seen, in large part because of the healthcare and bio founders we had the privilege of working with. YC has now funded over 500 bio and healthcare companies, and the... |
05.09.2023 | Create a ‘permissionless’ pilot program that drives sales and delights customers | Jake Jolis Contributor Share on X Jake Jolis is a partner at Matrix Partners, where he invests in seed and Series A technology companies, with a focus on natural language processing. More posts by this contributor Create a ‘permissionless’ ... |